Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Cibinqo (abrocitinib) - Pfizer
Opzelura (ruxolitinib cream) - Incyte
Vtama (tapinarof) - Organon
Jakafi (ruxolitinib) - Incyte
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Daliresp (roflumilast) - AstraZeneca
Rinvoq (upadacitinib) - AbbVie
Olumiant (baricitinib) - Eli Lilly
Nemluvio (nemolizumab-ilto) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/40562170
 
Amy S Paller; Kennedy Gallagher; Sofia Halperin-Goldstein
 
Jun 26, 2025
 
Next